Placental transfer of maternal rubella antibodies to full-term and preterm infants

Infection

Volumn 27, Issue 3, 1999, Pages 203-207

  Linder, Nehama ^a   Sirota, Lea ^a   Aboudy, Y ^b   German, B ^b   Lifshits, Tania ^b   Barnea, B S ^b   Lieberman, B ^a   Mendelson, Ella ^b   Barzilai, A ^b  

^a Pediatric Hematology Oncology   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RUBELLA ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; ISRAEL; LABOR; MAJOR CLINICAL STUDY; MATERNAL BLOOD; NEWBORN; PLACENTAL TRANSFER; PREMATURITY; RUBELLA; UMBILICAL CORD BLOOD; VERY LOW BIRTH WEIGHT;

ANTIBODIES, VIRAL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT, NEWBORN; INFANT, PREMATURE; MALE; NEUTRALIZATION TESTS; PLACENTA; RUBELLA;

EID: 0032996487     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02561529     Document Type: Article

References (23)

1. 1. Horstmann, D. M., Liebhaber, H., Le Bouvier, G. L., Rosenberg, D. A., Halstead, S. B.: Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic. N. Engl. J. Med. 283 (1970) 771-778.
2. 2. Morgan-Capner, P.: Does rubella reinfection matter? In: Mortimer, P. P. (ed.): Public health virology, 12 reports. Public Health Laboratory Service, London 1986, pp. 50-62.
3. 3. Robinson, J., Lemay, M., Vaudry, W. L.: Congenital rubella after anticipated maternal immunity, two cases and review of the literature. Pediatr. Infect. Dis. 13 (1994) 812-815.
4. 4. Aboudy, Y., Fogel, A., Barnea, B., Mendelson, E., Yosef, L., Frank, T., Shalev, E.: Subclinical rubella reinfection during pregnancy followed by transmission of view to the fetus. J. Infect 34 (1997) 273-276.
5. 5. Stewart, G. L., Parkman, P. D., Hopps. H. E., Douglas, R. D., Hamilton, J. P., Meyer, H. M. Jr.: Rubella virus haemagglutination-inhibition test. N. Engl. J. Med. 276 (1967) 554-557.
6. 6. Fogel, A., Handsher, R., Barnea, B.: Subclinical rubella in pregnancy - occurrence and outcome. Isr. J. Med. Sci. 21 (1985) 133-138.
7. 7. BMDP Statistical Software: Dixon, W. J. (ed.). University of California Press, Berkeley 1990.
8. 8. Kohler, P. F., Farr, R. S.: Elevation of cord over maternal IgG immunoglobulin: evidence for active placental IgG transport. Nature 210 (1966) 1070-1071.
9. 9. Evans, H. E., Akpata, S. O., Glass, L.: Serum immunoglohulin levels in premature and full term infants. Am. J. Clin. Pathol. 56 (1971) 416-418.
10. 10. Asahi, T., Ueda, K., Hidaka, Y., Miyazaki, C., Tanaka, Y., Nishima, S.: Twenty three year follow up study of rubella antibodies after immunization in a closed population and serological response to revaccination. Vaccine 15 (1997) 1791-1795.
11. 11. Gotlieb-Stematsky, T., Meron, I., Modan, M., Sayar, Y., Leventon-Kriss S., Fogel, A., Gurewitz, R., Insler, V.: Viral antibodies in maternal and cord sera. Med. Microbiol. Immunol. 172 (1983) 67-74.
12. 12. Sato, H., Albrecht, P., Reynolds, D. W., Stagno, S., Ennis, F. A.: Transfer of measles, mumps and rubella antibodies from mother to infant. Am. J. Dis. Child 133 (1979) 1240-1245.
13. 13. Brouwer, R., de Groot, I. G., Verheij, F. B.: Comparison of maternal and cord serum titers for measles and rubella antibodies. Arch. Gesamte Virusforsch. 44 (1974) 237-242.
14. 14. Dennin, R. H., Husstedt, W.: (Specific antibodies to herpes simplex virus, cytomegalovirus and rubella virus: distribution in amniotic fluid and blood). Geburtshilfe-Frauenheilkd. 46 (1986) 873-876.
15. 15. Suganuma, M., Kohno, S., Kohase, M., Shimizu, Y.: Occurrence of rubella virus lacking hemagglutination activity. Brief report. Arch. Gesamte Virusforsch. 29 (1970) 263-266.
16. 16. Lennette, E. H., Schmidt, N. J., Maggofin, R. L.: The hemagglutination inhibition lest for rubella: a comparison of its sensitivity to that of neutralization, complement fixation and fluorescent antibody tests for diagnosis of infection and determination of immunity status. J. Immunol. 99 (1967) 785-793.
17. 17. Field, A. M., Vandervelde, E. M., Thompson, K. M., Hutchinson, D. N.: A comparison of the haemagglutination-inhibition test and the neutralisation test for the detection of rubella antibody. Lancet ii (1967) 182-184.
18. 18. Schluederberg, A., Horstmann, D. M., Andiman, W. A., Randolph, M. F.: Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees naturally immune individuals. J. Infect. Dis. 138 (1978) 877-883.
19. 19. National Committee for Clinical Laboratory Standards: Villanova, PA, 12 (1992) 1-3.
20. 20. Skendzel, L. P.: Rubella immunity: defining the level of protective antibody. Am. J. Clin. Pathol. 106 (1996) 170-174.
21. 21. Forsgren, M.: Standardization of techniques and reagents for the study of rubella antibody. Rev. Infect. Dis. 7 (1985) S129-S132.
22. 22. Usonis, V., Bakasenas, V., Chitour, K., Clemens, R.: Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children. Infection 26 (1998) 222-226.
23. 23. Singh, R., John, T. J., Cherian,T., Raghupathy, P.: Immune response to measles, mumps and rubella vaccine at 9, 12, and 15 months of age. Indian J. Med. Res. 100 (1994) 155-159.